Mannkind (MNKD) Current Assets (2010 - 2026)
Mannkind (MNKD) posted quarterly Current Assets of $251.2 million for Q1 2026, down 8.25% year-over-year from $273.7 million in Q1 2025, and down 13.86% quarter-over-quarter from $291.6 million in Q4 2025.
Mannkind (MNKD) Current Assets (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Current Assets for 17 consecutive years, with $251.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 8.25% year-over-year to $251.2 million; the TTM figure through Mar 2026 stood at $251.2 million (down 8.25% YoY), while the FY2025 annual figure was $291.6 million, up 8.67% from the prior year.
- Current Assets retreated to $251.2 million in Q1 2026 per MNKD's latest filing, from $291.6 million in the prior quarter.
- Across five years, Current Assets topped out at $383.1 million in Q1 2024 and bottomed at $184.3 million in Q1 2022.
- Historically, Current Assets has averaged $273.1 million across 5 years, with a median of $268.3 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets tumbled 36.09% — and 2024, when it soared 71.56%.
- Mannkind's Current Assets stood at $234.9 million in 2022, then surged by 58.96% to $373.4 million in 2023, then retreated by 28.14% to $268.3 million in 2024, then gained by 8.67% to $291.6 million in 2025, then slipped by 13.86% to $251.2 million in 2026.
- Business Quant data shows MNKD's Current Assets at $251.2 million in Q1 2026, $291.6 million in Q4 2025, and $358.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 245.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 245.71 Mn |
| Mar 31, 2026 | 251.16 Mn |
| Dec 31, 2025 | 291.58 Mn |
| Sep 30, 2025 | 358.84 Mn |
| Jun 30, 2025 | 279.03 Mn |
| Mar 31, 2025 | 273.74 Mn |
| Dec 31, 2024 | 268.31 Mn |
| Sep 30, 2024 | 327.66 Mn |
| Jun 30, 2024 | 325.94 Mn |
| Mar 31, 2024 | 383.10 Mn |
| Dec 31, 2023 | 373.39 Mn |
| Sep 30, 2023 | 225.58 Mn |
| Jun 30, 2023 | 230.23 Mn |
| Mar 31, 2023 | 223.30 Mn |
| Dec 31, 2022 | 234.90 Mn |
| Sep 30, 2022 | 218.38 Mn |
| Jun 30, 2022 | 193.48 Mn |
| Mar 31, 2022 | 184.27 Mn |
| Dec 31, 2021 | 219.49 Mn |
| Sep 30, 2021 | 159.21 Mn |